BMS, Breyanzi, Mota-T Ciwon ƙwayar cuta, T-Cell CAR, CART far, USFDA
Breyanzi - Sabon C-T-Cell far daga BMS
Yuli 2021: Breyanzi (Lisocabtagene maraleucel; liso-cel), wani labari CD19-directed chimeric antigen receptor (CAR) T cell magani wanda Bristol Myers Squibb (BMS) ya haɓaka, Hukumar Abinci da Magunguna ta Amurka (US.
Mota-T Ciwon ƙwayar cuta, CART far, China CAR T Cell farfadowa, Cutar sankarar bargo, T Cell cutar sankarar bargo
CAR T-Cell far don T-cell m lymphoblastic cutar sankarar bargo (T-ALL)
Yuni 2021: Dangane da albarkatunmu, wani asibiti a kasar Sin ya kirkiro CAR T-Cell therapy don T-cell m lymphoblastic leukemia (T-ALL). Sunan furotin a cikin wannan yanayin shine CD7. An gwada marasa lafiya 5 tare da maganin, kuma ...
Akalabrutunib, Avelumab, CART far, Dabrafanib, Kimiya, Sabbin magunguna, Midostaurin, Niraparib, Pembrolizumab, Tecartus, Tisagenlecleucel, Trametinib, USFDA
Sabbin magunguna na maganin cutar kansa
Yuli 2021: Duba sabbin magunguna a cikin maganin cutar kansa. Kowace shekara, bayan nazarin gwaje-gwajen da wasu muhimman abubuwa, USFDA ta amince da kwayoyi, don haka masu ciwon daji za su iya gaskata cewa magani ya kusa. ..